Envista Holdings Corp NVST NYSE

NYSE • Healthcare • Medical - Equipment & Services • US • USD

SharesGrow Score

43/100

0/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Envista Holdings Corp (NVST), dont 36 achats et 11 ventes. Le total des achats d'initiés s'élève à $7.05M et le total des ventes d'initiés à $3.39M.

Les initiés notables ayant une activité récente comprennent Hammes Eric D., Keel Paul A, Nance Mark E. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — NVST

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-02-25	Hammes Eric D.	Chief Financial Officer	Attribution de RSU	29,225	-	-	29,225
2026-02-25	Keel Paul A	Chief Executive Officer	Attribution de RSU	115,320	$29.59	$3.41M	115,320
2026-02-25	Nance Mark E	General Counsel	Attribution de RSU	23,070	-	-	23,070
2026-02-25	Reis Mischa	SVP, Strategy & Bus. Dev.	Attribution de RSU	10,770	-	-	10,770
2026-02-25	Kaabi Faez C	Chief Accounting Officer	Retenue Fiscale RSU	4,964	$29.59	$146.88K	45,032
2026-02-25	Befidi Robert	President, Diagnostics	Attribution de RSU	13,845	-	-	13,845
2026-02-25	Nilsson Stefan	President, Nobel Biocare	Attribution de RSU	13,845	-	-	13,845
2026-02-25	Acurio Veronica	President, Orthodontics	Attribution de RSU	13,845	-	-	13,845
2026-02-10	Reis Mischa	SVP, Strategy & Bus. Dev.	Exercice d'Options (Vente)	5,634	$15.97	$89.97K	-
2026-02-01	Hammes Eric D.	Chief Financial Officer	Attribution de RSU	1,119	-	-	1,119
2026-02-01	Keel Paul A	Chief Executive Officer	Attribution de RSU	4,091	-	-	4,091
2026-02-01	Nance Mark E	General Counsel	Attribution de RSU	2,006	-	-	7,587
2026-02-01	Reis Mischa	SVP, Strategy & Bus. Dev.	Attribution de RSU	2,919	-	-	29,357
2026-02-01	Kaabi Faez C	Chief Accounting Officer	Attribution de RSU	1,186	-	-	5,040
2026-02-01	Befidi Robert	President, Diagnostics	Attribution de RSU	998	-	-	2,149
2026-02-01	Acurio Veronica	President, Orthodontics	Attribution de RSU	998	-	-	998
2025-11-01	Keel Paul A	Chief Executive Officer	Retenue Fiscale RSU	54,097	$20.35	$1.1M	347,555
2025-08-25	Hammes Eric D.	Chief Financial Officer	Retenue Fiscale RSU	7,654	$21.12	$161.65K	96,788
2025-08-25	Reis Mischa	SVP, Strategy & Bus. Dev.	Vente Informative	15,000	$21.60	$324K	32,382
2025-08-25	Befidi Robert	President, Diagnostics	Retenue Fiscale RSU	3,454	$21.12	$72.95K	45,504
2025-08-25	Nilsson Stefan	President, Nobel Biocare	Retenue Fiscale RSU	804	$21.12	$16.98K	54,941
2025-08-25	Acurio Veronica	President, Orthodontics	Retenue Fiscale RSU	5,422	$21.12	$114.51K	50,323
2025-07-14	Pierce James Andrew	Director	Inconnu	-	-	-	-
2025-07-14	Pierce James Andrew	Director	Attribution de RSU	9,155	-	-	9,155
2025-06-10	Tsingos Christine A	Director	Attribution de RSU	10,450	-	-	50,600
2025-06-10	Raskas Daniel	Director	Attribution de RSU	10,450	-	-	44,680
2025-06-10	Gallahue Kieran	Director	Attribution de RSU	10,450	-	-	44,680
2025-06-10	Huennekens R Scott	Director	Attribution de RSU	14,370	-	-	69,520
2025-06-10	Jain Vivek	Director	Attribution de RSU	10,450	-	-	43,615
2025-06-10	Carruthers Wendy	Director	Attribution de RSU	10,450	-	-	50,610
2025-06-10	Hulit Barbara B.	Director	Attribution de RSU	10,450	-	-	79,820
2025-05-25	Keel Paul A	Chief Executive Officer	Retenue Fiscale RSU	12,787	$16.72	$213.8K	401,652
2025-02-26	Reis Mischa	SVP, Strategy & Bus. Dev.	Attribution de RSU	8,475	-	-	47,382
2025-02-25	Hammes Eric D.	Chief Financial Officer	Attribution de RSU	28,995	-	-	28,995
2025-02-25	Keel Paul A	Chief Executive Officer	Attribution de RSU	153,660	$20.66	$3.17M	153,660
2025-02-25	Nance Mark E	General Counsel	Attribution de RSU	33,455	-	-	33,455
2025-02-25	Reis Mischa	SVP, Strategy & Bus. Dev.	Attribution de RSU	15,615	-	-	15,615
2025-02-25	Kaabi Faez C	Chief Accounting Officer	Attribution de RSU	22,600	$20.66	$466.92K	22,600
2025-02-25	Befidi Robert	President, Diagnostics	Attribution de RSU	18,960	-	-	18,960
2025-02-25	Nilsson Stefan	President, Nobel Biocare	Attribution de RSU	18,960	-	-	18,960
2025-02-25	Acurio Veronica	President, Orthodontics	Attribution de RSU	18,960	-	-	18,960
2025-02-01	Nance Mark E	General Counsel	Attribution de RSU	965	-	-	5,581
2025-02-01	Reis Mischa	SVP, Strategy & Bus. Dev.	Attribution de RSU	3,152	-	-	26,438
2025-02-01	Kaabi Faez C	Chief Accounting Officer	Attribution de RSU	689	-	-	3,854
2025-02-01	Befidi Robert	President, Diagnostics	Attribution de RSU	1,151	-	-	1,151
2024-11-18	Nilsson Stefan	President, Nobel Biocare	Inconnu	-	-	-	45,455
2024-11-18	Acurio Veronica	President, Orthodontics	Inconnu	-	-	-	45,455
2024-11-01	Keel Paul A	Chief Executive Officer	Retenue Fiscale RSU	53,996	$20.94	$1.13M	348,609
2024-09-17	Reis Mischa	SVP, Strategy & Bus. Dev.	Retenue Fiscale RSU	812	$19.00	$15.43K	42,720
2024-08-25	Hammes Eric D.	Chief Financial Officer	Attribution de RSU	64,175	-	-	88,707

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration